Medizinische Universität Graz - Research portal
Aldenhoff Ursula |
** = Publications listed in SCI/SSCI/Pubmed
2005
Full paper/article (Journal)
** Wascher, TC; Boes, U
Forearm vascular reactivity is differentially influenced by gliclazide and glibenclamide in chronically treated type 2 diabetic patients.
Clin Physiol Funct Imaging. 2005; 25(1):40-46
Doi: 10.1111/j.1475-097X.2004.00580.x
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2003
Review
** Wascher, TC; Boes, U
Ischemia in type 2 diabetes: tissue selectivity of sulfonylureas and clinical implications.
Metabolism. 2003; 52(8 Suppl 1):3-5
Doi: 10.1016/S0026-0495(03)00211-7
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
2002
Full paper/article (Journal)
** Stanger, O; Semmelrock, HJ; Wonisch, W; Bös, U; Pabst, E; Wascher, TC
Effects of folate treatment and homocysteine lowering on resistance vessel reactivity in atherosclerotic subjects.
J Pharmacol Exp Ther. 2002; 303(1):158-162
Doi: 10.1124/jpet.102.036715
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Abstract (Journal)
** Wascher, TC; Boes, U
Different effects of glibenclamide and gliclazide on forearm vascular reserve in Type-2 diabetic patients.
DIABETOLOGIA 2002 45: 854-854.
Web of Science
2001
Full paper/article (Journal)
** Boes, U; Wallner, S; Wascher, TC
Acute effects of nicorandil on glucose tolerance in subjects with borderline fasting blood glucose levels.
Wien Klin Wochenschr. 2001; 113(3-4):127-129
Web of Science
PubMed
Google Scholar
1999
Abstract (Journal)
** Boes, U; Klaus, E; Dittrich, P; Wascher, TC
Postprandial incrases of circulating methylglyoxal in type-II diabetic and non-diabetic subjects.
DIABETOLOGIA 1999 42: A327-A327.
Web of Science